The role of norepinephrine in epilepsy: From the bench to the bedside

Neuroscience and Biobehavioral Reviews

Volumn 28, Issue 5, 2004, Pages 507-524

  Giorgi, Filippo S ^a   Pizzanelli, Chiara ^a   Biagioni, Francesca ^b   Murri, Luigi ^a   Fornai, Francesco ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

Epilepsy; Locus coeruleus; Norepinephrine; Norepinephrine system in epilepsy; Seizures

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; CLONIDINE; DESIPRAMINE; DOBUTAMINE; ISOPRENALINE; NORADRENALIN; RESERPINE; TERBUTALINE;

EPILEPSY; GENE EXPRESSION; GENETIC PREDISPOSITION; KINDLING; KNOCKOUT MOUSE; LIMBIC SYSTEM; NERVE STIMULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; VAGAL NERVE STIMULATION;

EID: 4744359163     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2004.06.008     Document Type: Article

References (175)

1. S.E. Krahl, K.B. Clark, D.C. Smith, and R.A. Browning Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation Epilepsia 39 1998 709 714
2. M.S. George, H.A. Sackeim, A.J. Rush, L.B. Marangell, Z. Nahas, M.M. Husain, S. Lisanby, T. Burt, J. Goldman, and J.C. Ballenger Vagus nerve stimulation: a new tool for brain research and therapy Biol Psychiatry 47 2000 287 295
3. S.C. Schachter Vagus nerve stimulation therapy summary: five years after FDA approval Neurology 59 6 Suppl 4 2002 S15 S20
4. M.S. George, A.J. Rush, H.A. Sackeim, and L.B. Marangell Vagus nerve stimulation (VNS): utility in neuropsychiatric disorders Int J Neuropsychopharmacol 6 2003 73 83
5. D. Chadwick The epidemiology of drug resistant epilepsy and adverse effects of antiepileptic drugs Acta Neurochir Suppl (Wien) 50 1990 32 37
6. J. Engel Jr, S. Wiebe, J. French, M. Sperling, P. Williamson, D. Spencer, R. Gumnit, C. Zahn, E. Westbrook, B. Enos, Quality Standards Subcommittee of the American Academy of Neurology, American Epilepsy Society, and American Association of Neurological Surgeons Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons Neurology 60 2003 538 547
7. G. Chen, G.F. Ensor, and B. Bohner A facilitation of reserpine on the central nervous system Proc Soc Exp Biol Med 86 1954 507 510
8. R. Oishi, N. Suenaga, and T. Fukuda Possible involvement of brainstem norepinephrine in pentylenetetrazol convulsion in rats Pharmacol Biochem Behav 10 1979 57 61
9. P.K. Mishra, R.L. Burger, A.F. Bettendorf, R.A. Browning, and P.C. Jobe The role of norepinephrine in forebrain and brainstem seizures: chemical lesioning of locus coeruleus with DSP4 Exp Neurol 125 1994 58 64
10. M.E. Corcoran, and S.T. Mason Role of forebrain catecholamines in amygdaloid kindling Brain Res 190 1980 473 484
11. D.C. McIntyre Catecholamines involvement in amygdala kindling of the rat J.A. Wada Kindling 1981 Raven Press New York 67 80
12. D.C. McIntyre, and R.K. Wong Cellular and synaptic properties of amygdala-kindled piriform cortex in vitro J Neurophysiol 55 1986 1295 1307
13. D.C. McIntyre Amygdala kindling in rats: facilitation after local amygdala norepinephrine depletion with 6-hydroxydopamine Exp Neurol 69 1980 395 407
14. M.E. Corcoran Characteristics of accelerated kindling after depletion of noradrenaline in adult rats Neuropharmacology 27 1988 1081 1084
15. J.W. Dailey, and P.C. Jobe Indices of noradrenergic function in the central nervous system of seizure-naive genetically epilepsy-prone rats Epilepsia 27 1986 665 670
16. R.A. Browning, D.R. Wade, M. Marcinczyk, G.L. Long, and P.C. Jobe Regional brain abnormalities in norepinephrine uptake and dopamine beta-hydroxylase activity in the genetically epilepsy-prone rat J Pharmacol Exp Ther 249 1989 229 235
17. K. Gale Subcortical structures and pathways involved in convulsive seizure generation J Clin Neurophysiol 9 1992 264 277
18. A. Dahlstroem, and K. Fuxe Evidence for the existence of monoamine-containing neurons in the central nervous system. I Demonstration of monoamines in the cell bodies of brain stem neurons Acta Physiol Scand 62 1964 1 55
19. A. Dahlstroem, and K. Fuxe Evidence for the existence of monoamine neurons in the central nervous system Acta Physiol Scand 64 1965 1 36
20. G.V. Russell The nucleus locus coeruleus (dorsolateralis tegmenti) Tex Rep Biol Med 13 1955 939 988
21. a. Brodal The reticular formation and some related nuclei. The nucleus locus coeruleus A. Brodal Neurological anatomy in relation to clinical medicine 3rd ed 1981 Oxford University Press New York 416 419
22. G. Aston-Jones, and M.T. Shipley The locus coeruleus, A5 and A7 noradrenergic cell groups G. Paxinos The rat nervous system 2nd ed 1995 Academic Press New York 183 213
23. J.V. Nieuwenhuys, J. Voogd, and C. vanHuijzen The human central nervous system: a synopsis and atlas 1988 Springer Berlin
24. J.M. Woulfe, B.A. Fluferfelt, and A.W. Hrycyshyn Efferent connections of the A1 noradrenergic cell group: a DBH immunohistochemical and PHA-L anterograde tracing study Exp Neurol 109 1990 308 322
25. D.G. Ward, and C.G. Gunn Locus coeruleus complex: elicitation of a pressor response and a brainstem region necessary for its occurrence Brain Res 107 1976 401 406
26. S.L. Foote, F.E. Bloom, and G. Aston-Jones Nucleus locus coeruleus: new evidence of anatomical and physiological specificity Physiol Rev 63 1983 844 914
27. M. Jouvet Biogenic amines and the states of sleep Science 163 1969 32 41
28. G. Aston-Jones, and F.E. Bloom Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle J Neurosci 1 1981 876 886
29. G. Aston-Jones, C. Chiang, and T. Alexinski Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance C.D. Barnes O. Pompeiano Progress in Brain Research vol. 88 1991 Elsevier Amsterdam 501 520
30. G. Aston-Jones, J. Rajkowski, P. Kubiak, and T. Alexinski Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task J Neurosci 14 1994 4467 4480
31. M. Culic, J. Saponjic, B. Jankovic, S. Udovic, S. Popovic, and L. Rakic Effect of neurotoxin DSP4 on EEG power spectra in the rat acute model of epilepsy Neurosci Lett 196 1995 49 52
32. F.S. Giorgi, M. Ferrucci, G. Lazzeri, C. Pizzanelli, P. Lenzi, M.G. Alessandrl, L. Murri, and F. Fornai A damage to locus coeruleus neurons converts sporadic seizures into self-sustaining limbic status epilepticus Eur J Neurosci 17 2003 2593 2601
33. P. Riekkinen Jr, J. Sirvio, A. Valjakka, A. Pitkanen, J. Partanen, and P. Riekkinen The effects of concurrent manipulations of cholinergic and noradrenergic systems on neocortical EEG and spatial learning Behav Neural Biol 54 1990 204 210
34. A.Y. Chang, T.B. Kuo, T.H. Tsai, C.F. Chen, and S.H. Chan Power spectral analysis of electroencephalographic desynchronization induced by cocaine in rats: correlation with evaluation of noradrenergic neurotransmission at the medial prefrontal cortex Synapse 21 1995 149 157
35. C. Cirelli, M. Pompeiano, and G. Tononi Neuronal gene expression in the waking state: a role for the locus coeruleus Science 274 1996 1212 1215
36. C. Cirelli, and G. Tononi Differential expression of plasticity-related genes in waking and sleep and their regulation by the noradrenergic system J Neurosci 20 2000 9187 9194
37. R.M. Gubits, T.M. Smith, J.L. Fairhurst, and H. Yu Adrenergic receptors mediate changes in c-fos mRNA levels in brain Mol Brain Res 6 1989 39 45
38. G. Bing, D. Filer, J.C. Miller, and E.A. Stone Noradrenergic activation of immediate early genes in rat cerebral cortex Mol Brain Res 11 1991 43 46
39. E.A. Stone, Y. Zhang, S. John, D. Filer, and G. Bing Effect of locus coeruleus lesion on c-fos expression in the cerebral cortex caused by yohimbine injection or stress Brain Res 603 1993 181 185
40. S. Simler, M. Vergnes, and C. Marescaux Spatial and temporal relationships between c-fos expression and kindling of audiogenic seizures in Wistar rats Exp Neurol 157 1999 106 119
41. C. Cirelli, C.M. Gutierrez, and G. Tononi Extensive and divergent effects of sleep and wakefulness on brain gene expression Neuron 41 2004 35 43
42. P.J. Shen, T.C.D. Burazin, and A.L. Gundlach Noradrenergic regulation of immediate early gene expression in rat forebrain: differential effect of alpha1- and alpha2-adrenoceptor drugs Mol Brain Res 28 1995 222 230
43. W.F. Hopkins, and D. Johnston Noradrenergic enhancement of long-term potentiation at mossy fiber synapses in the hippocampus J Neurophysiol 59 1988 667 687
44. R.S. Neuman, and C.W. Harley Long-lasting potentiation of the dentate gyrus population spike by norepinephrine Brain Res 273 1983 162 165
45. K. Kobayashi, and Y. Yasoshima The central noradrenaline system and memory consolidation Neuroscientist 7 2001 371 376
46. K. Kobayashi, and T. Kobayashi Genetic evidence for noradrenergic control of long-term memory consolidation Brain Dev 23 Suppl 1 2001 S16 S23
47. T. Nagai, K. Satoh, K. Immamoto, and T. Maeda Divergent projections of catecholamine neurons of the locus coeruleus as revealed by fluorescent retrograde double labeling technique Neurosci Lett 23 1981 117 123
48. P. Room, F. Postema, and J. Korf Divergent axon collaterals of rat locus coeruleus neurons: demonstration by a fluorescent double-labeling technique Brain Res 221 1981 219 230
49. S.I. Harik, and T. McGunigal Jr The protective influence of the locus coeruleus on the blood-brain barrier Ann Neurol 15 1984 568 574
50. E.A. Stone, and M.A. Ariano Are glial cells targets of the central noradrenergic system? A review of the evidence Brain Res Rev 14 1989 297 309
51. F. Fornai, L. Bassi, M.T. Torracca, M.G. Alessandrì, V. Scalori, and G.U. Corsini Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents Neurodegeneration 5 1996 241 249
52. P.J. Reading, and S.B. Dunnett 6-Hydroxydopamine lesions of nigrostriatal neurons as an animal model of Parkinson's disease M.L. Woodruff A.J. Nonneman Toxins-induced models of neurological disorders 1994 Plenum Press New York 89 119
53. P. Lidbrink, and G. Jonsson Noradrenaline nerve terminals in the cerebral cortex: effects on noradrenaline uptake and storage following axonal lesion with 6-hydroxydopamine J Neurochem 22 1974 617 626
54. J. Luthman, A. Fredriksson, E. Sundstrom, G. Jonsson, and T. Archer Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage Behav Brain Res 33 1989 267 277
55. S. Hansen, C. Kohler, and S.B. Ross On the role of the dorsal mesencephalic tegmentum in the control of masculine sexual behavior in the rat: effects of electrolytic lesions, ibotenic acid and DSP 4 Brain Res 240 1982 311 320
56. J. Harro, L. Oreland, E. Vasar, and J. Bradwejn Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation Eur Neuropsychopharmacol 5 1995 447 455
57. T. Archer, S.O. Ogren, G. Johansson, and S.B. Ross DSP4-induced two-way active avoidance impairment in rats: involvement of central and not peripheral noradrenaline depletion Psychopharmacology 76 1982 303 309
58. G. Jonsson, H. Hallman, F. Ponzio, and S. Ross DSP4 (N-(2-chloroethyl)-N- ethyl-2-bromobenzylamine) - a useful denervation tool for central and peripheral noradrenaline neurons Eur J Pharmacol 72 1981 173 188
59. J.M. Fritschy, and R. Grzanna Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals Neuroscience 30 1989 181 197
60. F. Fornai, F.S. Giorgi, M. Gesi, K. Chen, M.G. Alessandrì, and J.C. Shih Biochemical effects of the monoamine neurotoxins DSP-4 and MDMA in specific brain regions of MAO-B-deficient mice Synapse 39 2001 213 221
61. E.D. Abercrombie, and M.J. Zigmond Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis J Neurosci 9 1989 4062 4067
62. F.H. Gage, A. Bjorklund, and U. Stenevi Local regulation of compensatory noradrenergic hyperactivity in the partially denervated hippocampus Nature. 303 1983 819 821
63. Z.A. Hughes, and S.C. Stanford A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a microdialysis study in vivo Psychopharmacology 136 1998 299 303
64. P.S. Arnold, R.J. Racine, and P.A. Wise Effects of atropine, reserpine, 6-hydroxydopamine and handling on seizure development in the rat Exp Neurol 40 1973 457 470
65. D.C. McIntyre, M. Saari, and B.A. Pappas Potentiation of amygdala kindling in adult or infants rats by injections of 6-hydroxydopamine Exp Neurol 63 1979 527 544
66. I.M. Altman, and M.E. Corcoran Facilitation of neocortical kindling by depletion of forebrain noradrenaline Brain Res 270 1983 174 177
67. D.C. McIntyre, N. Edson, G. Chao, and V. Knowles Differential effect of acute vs chronic desmethylimipramine on the rate of amygdala kindling in rats Exp Neurol 78 1982 158 166
68. C. Jimenez-Rivera, A. Voltura, and G.K. Weiss Effect of locus coeruleus stimulation on the development of kindled seizures Exp Neurol 95 1986 13 20
69. D.I. Barry, I. Kikvadze, P. Brundin, T.G. Bolwig, A. Bjorklund, and O. Lindvall Grafted noradrenergic neurons suppress seizure development in kindling-induced epilepsy Proc Natl Acad Sci USA 84 1987 8712 8715
70. M. Kokaia, M.A. Cenci, E. Elmer, O.G. Nilsson, Z. Kokaia, J. Bengzon, A. Bjorklund, and O. Lindvall Seizure development and noradrenaline release in kindling epilepsy after noradrenergic reinnervation of the subcortically deafferented hippocampus by superior cervical ganglion or fetal locus coeruleus grafts Exp Neurol 30 1994 351 361
71. D.I. Barry, B. Wanscher, J. Kragh, T.G. Bolwig, M. Kokaia, P. Brundin, A. Bjorklund, and O. Lindvall Grafts of fetal locus coeruleus neurons in rat amygdala-piriform cortex suppress seizure development in hippocampal kindling Exp Neurol 106 1989 125 132
72. M.A. Cenci, O.G. Nilsson, P. Kalen, and A. Bjorklund Characterization of in vivo noradrenaline release from superior cervical ganglia or fetal locus coeruleus transplanted to the subcortically deafferented hippocampus in the rat Exp Neurol 122 1993 73 87
73. Y. Murata, T. Chiba, P. Brundin, A. Bjorklund, and O. Lindvall Formation of synaptic graft-host connections by noradrenergic locus coeruleus neurons transplanted into the adult rat hippocampus Exp Neurol 110 1990 258 267
74. J. Bengzon, Z. Kokaia, and O. Lindvall Specific functions of grafted locus coeruleus neurons in the kindling model of epilepsy Exp Neurol 122 1993 143 154
75. R.A. Gross, and J.A. Ferrendelli Effects of reserpine, propranolol, and aminophylline on seizure activity and CNS cyclic nucleotides Ann Neurol 6 1979 296 301
76. M.P. Logue, J.H. Growdon, I.L. Coviella, and R.J. Wurtman Differential effects of DSP-4 administration on regional brain norepinephrine turnover in rats Life Sci 37 1985 403 409
77. M. Jerlicz, W. Kostowski, A. Bidzinski, M. Hauptman, and J. Dymecki Audiogenic seizures in rats: relation to noradrenergic neurons of the locus coeruleus Acta Physiol Pol 29 1978 409 412
78. S.T. Mason, and M.E. Corcoran Catecholamines and convulsions Brain Res 170 1979 497 507
79. S. Trottier, O. Lindvall, P. Chauvel, and A. Bjorklund Facilitation of focal cobalt-induced epilepsy after lesions of the noradrenergic locus coeruleus system Brain Res 454 1988 308 314
80. B. Libet, C.A. Gleason, E.W. Wright Jr, and B. Feinstein Suppression of an epileptiform type of electrocortical activity in the rat by stimulation in the vicinity of locus coeruleus Epilepsia 18 1977 451 462
81. G.K. Weiss, J. Lewis, C. Jimenez-Rivera, A. Vigil, and M.E. Corcoran Antikindling effects of locus coeruleus stimulation: mediation by ascending noradrenergic projections Exp Neurol 108 1990 136 140
82. G. Ferraro, P. Sardo, M. Sabatino, and V. La Grutta Locus coeruleus noradrenaline system and focal penicillin hippocampal epilepsy: neurophysiological study Epilepsy Res 19 1994 215 220
83. S. Piredda, and K. Gale Evidence that the deep prepiriform cortex contains a crucial epileptogenic site Nature 317 1985 623 625
84. F. Fornai, D.J. Dybdal, M.R. Proctor, and K. Gale Focal intracerebral elevation of l-lactate is anticonvulsant Eur J Pharmacol 254 1994 R1 R2
85. M.R. Proctor, F. Fornai, J.K. Afshar, and K. Gale The role of nitric oxide in focally-evoked limbic seizures Neuroscience 76 1997 1231 1236
86. J.H. Fallon, and R.Y. Moore Catecholamine innervation of the basal forebrain. III. Olfactory bulb, anterior olfactory nuclei, olfactory tubercle and piriform cortex J Comp Neurol 180 1978 533 544
87. B.E. Jones, and T.Z. Yang The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat J Comp Neurol 242 1985 56 92
88. R. Racine Modification of seizure activity by electrical stimulation. Motor seizures Electroencephalogr Clin Neurophysiol 32 1972 281 294
89. F. Fornai, L. Bassi, M. Gesi, F.S. Giorgi, R. Guerrini, I. Bonaccorsi, and M.G. Alessandrì Similar increases in extracellular lactic acid in the limbic system during epileptic and/or olfactory stimulation Neuroscience 97 2000 447 458
90. D.C. German, K.F. Manaje, C.L. White, D.J. Woodward, D.D. McIntire, W.K. Smith, R.N. Kalaria, and D.M. Mann Disease specific pattern of locus coeruleus cell loss Ann Neurol 32 1992 667 676
91. M. Gesi, P. Soldani, F.S. Giorgi, A. Santinami, I. Bonaccorsi, and F. Fornai The role of the locus coeruleus in the development of Parkinson's disease Neurosci Biobehav Rev 24 2000 655 668
92. E.A. Stone, Y. Zhang, J.M. Hiller, E.J. Simon, and D.E. Hillman Activation of fos in mouse amygdala by local infusion of norepinephrine or atipamezole Brain Res 778 1997 1 5
93. E.A. Stone, Y. Zhang, S.M. John, and G. Bing c-Fos response to administration of catecholamines into brain by microdialysis Neurosci Lett 133 1991 33 35
94. R. Siciliano, F. Fornai, I. Bonaccorsi, L. Domenici, and P. Bagnoli Cholinergic and noradrenergic afferents influence the functional properties of the postnatal visual cortex in rats Vis Neurosci 16 1999 1015 1028
95. T. Shirokawa, and T. Ogawa Regulation of basal release of GABA by noradrenaline in the kitten visual cortex NeuroReport 5 1994 2037 2040
96. Y. Kawaguchi, and T. Shindou Noradrenergic excitation and inhibition of GABAergic cell types in rat frontal cortex J Neurosci 18 1998 6963 6976
97. G. Aston-Jones, and F.E. Bloom Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli J Neurosci 1 1981 887 900
98. D. Weinshenker, and P. Szot The role of catecholamines in seizure susceptibility: new results using genetically engineered mice Pharmacol Ther 94 2002 213 233
99. E. Tibirica, J. Feldman, C. Mermet, F. Gonon, and P. Bousquet An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan J Pharmacol Exp Ther 256 1991 606 613
100. D.C. Mc Intyre, and L. Giugno Effect of clonidine on amygdala kindling in normal and 6-hydroxydopamine-pretreated rats Exp Neurol 99 1988 96 106
101. J.L. Stringer, and E.W. Lothman Cholinergic and adrenergic agents modify the initiation and termination of epileptic discharges in the dentate gyrus Neuropharmacology 30 1991 59 65
102. Y. Kamisaki, T. Hamahashi, T. Hamada, K. Maeda, and T. Itoh Presynaptic inhibition by clonidine of neurotransmitter amino acid release in various brain regions Eur J Pharmacol 217 1992 57 63
103. R.L. Gellman, J.A. Kallianos, and J.O. McNamara Alpha-2 receptors mediate an endogenous noradrenergic suppression of kindling development J Pharmacol Exp Ther 241 1987 891 898
104. J.R. Unnerstall, T.A. Kopajtic, and M.J. Kuhar Distribution of α2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents Brain Res 7 1984 69 101
105. S.C. Stanford, and J.G.R. Jefferys Down-regulation of α2- and β-adrenoceptor binding sites in rat cortex caused by amygdalar kindling Exp Neurol 90 1985 108 117
106. M.N. Shouse, J. Langer, M. Bier, P.R. Farber, O. Alcalde, R. Moghimi, M. Richkind, and R. Szymusiak The alpha 2 adrenoreceptor agonist clonidine suppresses seizures, whereas the alpha 2 adrenoreceptor antagonist idazoxan promotes seizures: pontine microinfusion studies of amygdala-kindled kittens Brain Res 731 1996 203 207
107. H.Q. Wu, M. Tullii, R. Samanin, and A. Vezzani Norepinephrine modulated seizures induced by quinolinic acid in rats: selective and distinct roles of alpha-adrenoceptor subtypes Eur J Pharmacol 138 1987 309 318
108. W. Murmann, L. Almirante, and M. Saccani-Guelfi Central nervous system effects of four beta-adrenergic receptor blocking agents J Pharm Pharmacol 18 1966 317 318
109. B.R. Madan, and F.S. Barar Anticonvulsant activity of some beta-adrenoceptor blocking agents in mice Eur J Pharmacol 29 1974 1 4
110. H.W. Yang, Y.W. Lin, C.D. Yen, and M.Y. Min Change in bi-directional plasticity at CA1 synapses in hippocampal slices taken from 6-hydroxydopamine- treated rats: the role of endogenous norepinephrine Eur J Neurosci 16 2002 1117 1128
111. K.H. Ko, J.W. Dailey, and P.C. Jobe Evaluation of monoaminergic receptors in genetically epilepsy prone rat Experientia 40 1984 70 73
112. P.H. Holmes, and J.N. Crawley Coexisting neurotransmitters in central noradrenergic neurons F.E. Bloom D.J. Kupfer Psychopharmacology: the fourth generation of progress 1995 Raven Press New York 347 353
113. J.R. Cooper, F.E. Bloom, and R.H. Roth The biochemical basis of neuropharmacology 7th ed 1996 Oxford University Press New York
114. T.V. Dunwiddie Adenosine and suppression of seizures Adv Neurol 79 1999 1001 1010
115. A.M. Mazarati, E. Halaszi, and G. Telegdy Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats Brain Res 589 1992 164 166
116. A.M. Mazarati, J.G. Hohmann, A. Bacon, H. Liu, R. Sankar, R.A. Steiner, D. Wynick, and C.G. Wasterlain Modulation of hippocampal excitability and seizures by galanin J Neurosci 20 2000 6276 6281
117. S. Zini, M. Roisin, U. Langel, T. Bartfai, and Y. Ben-Ari Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus Eur J Pharmacol 245 1993 1 7
118. D.P. Woldbye, P.J. Larsen, J.D. Mikkelsen, K. Klemp, T.M. Madsen, and T.G. Bolwig Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors Nat Med 3 1997 761 764
119. D.P. Woldbye Antiepileptic effects of NPY on pentylenetetrazol seizures Regul Pept 75-76 1998 279 282
120. J.C. Erickson, K.E. Clegg, and R.D. Palmiter Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y Nature 381 1996 415 421
121. P. Consroe, A. Picchioni, and L. Chin Audiogenic seizure susceptible rats Fed Proc 38 1979 2411 2416
122. P.C. Jobe, A.L. Picchioni, and L. Chin Role of brain norepinephrine in audiogenic seizure in the rat J Pharmacol Exp Ther 184 1973 1 10
123. R.A. Browning, C. Wang, M.L. Lauber, and P.C. Jobe Electroshock and pentylentetrazol-induced seizures in genetically epilepsy-prone rats (GEPRs): differences in threshold and pattern Epilepsy Res 6 1990 1 11
124. J.E. Franck, K.L. Ginter, and P.A. Swartzkronin Developing genetically epilepsy-prone rats have an abnormal seizure response to fluorothyl Epilepsia 30 1989 1 6
125. D.D. Savage, C.E. Reigel, and P.C. Jobe Angular bundle kindling is accelerated in rats with a genetic predisposition to acoustic stimulus-induced seizures Brain Res 376 1986 412 415
126. J.W. Dailey, C.E. Reigel, P.K. Mishra, and P.C. Jobe Neurobiology of seizure predisposition in the genetically epilepsy-prone rats Epilepsy Res 3 1989 3 17
127. P.C. Jobe, P.K. Mishra, N. Ludvig, and J.W. Dailey Scope and contribution of genetic models to an understanding of the epilepsies Crit Rev Neurobiol 6 1991 183 220
128. P.C. Jobe, K.H. Ko, and J.W. Dailey Abnormalities in norepinephrine turnover rate in the central nervous system of the genetically epilepsy-prone rats Brain Res 290 1984 301 311
129. J.W. Dailey, P.K. Mishra, K.H. Ko, J.E. Penny, and P.C. Jobe Noradrenergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats Epilepsia 32 1991 168 173
130. J.C. Lauterborn, and C.E. Ribak Differences in dopamine β-hydroxylase immunoreactivity between the brains of genetically epilepsy-prone and Sprague-Dawley rats Epilepsy Res 4 1989 161 176
131. C.L. Faingold The genetically epilepsy-prone rat Gen Pharmacol 19 1988 331 338
132. P.K. Mishra, E.H. Kahle, A.F. Bettendorf, J.W. Dailey, and P.C. Jobe Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s) Life Sci 52 1993 1435 1441
133. Q.S. Yan, P.C. Jobe, and J.W. Dailey Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis Brain Res 610 1993 24 31
134. Q.S. Yan, J.W. Dailey, J.L. Steenbergen, and P.C. Jobe Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study Brain Res 780 1998 199 209
135. M.C. Green, and R.L. Sidman Tottering - a neuromusclar mutation in the mouse. And its linkage with oligosyndactylism J Hered 53 1962 233 237
136. P. Levitt, and J.L. Noebels Mutant mouse tottering: selective increase of locus ceruleus axons in a defined single-locus mutation Proc Natl Acad Sci USA 78 1981 4630 4634
137. J.L. Noebels A single gene error of noradrenergic axon growth synchronizes central neurones Nature 310 1984 409 411
138. J.L. Noebels, and P.A. Rutecki Altered hippocampal network excitability in the hypernoradrenergic mutant mouse tottering Brain Res 524 1990 225 230
139. S.A. Helekar, and J.L. Noebels Synchronous hippocampal bursting reveals network excitability defects in an epilepsy gene mutation Proc Natl Acad Sci USA 88 1991 4736 4740
140. C.F. Fletcher, C.M. Lutz, T.N. O'Sullivan, J.D. Shaughnessy Jr, R. Hawkes, W.N. Frankel, N.G. Copeland, and N.A. Jenkins Absence epilepsy in tottering mutant mice is associated with calcium channel defects Cell 87 1996 607 617
141. S.A. Thomas, A.M. Matsumoto, and R.D. Palmiter Noradrenaline is essential for mouse fetal development Nature 374 1995 643 646
142. P. Szot, D. Weinshenker, S.S. White, C.A. Robbins, N.C. Rust, P.A. Schwartzkroin, and R.D. Palmiter Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli J Neurosci 19 1999 10985 10992
143. M.J. Zuscick, S. Sands, S.A. Ross, D.J.J. Waugh, R.J. Gaivin, D. Morilak, and D.M. Perez Overexpression of the α1B adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy Nat Med 6 2000 1388 1394
144. T. Kunieda, M.J. Zuscick, A. Boongird, D.M. Perez, H.O. Luders, and I.M. Najm Systemic overexpression of the α1B adrenergic receptor in mice: an animal model of epilepsy Epilepsia 43 11 2002 1324 1329
145. S. Janumpalli, L.S. Butler, L.B. MacMillian, L.E. Limbird, and J.O. McNamara A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine J Neurosci 18 1998 2004 2008
146. B.P. Ceresa, and L.E. Limbird Mutation of an aspartate residue of highly conserved among G-protein-coupled receptors, results in nonreciprocal disruption of alpha 2-adrenergic receptor-G-protein interactions J Biol Chem 269 1994 29557 29564
147. R. Briere, A.L. Sherwin, Y. Robitaille, A. Olivier, L.F. Quesney, and T.A. Reader Alpha-1 adrenoceptors are decreased in human epileptic foci Ann Neurol 19 1986 26 30
148. S.V. Pacia, W.K. Doyle, and P.A. Broderick Biogenic amines in the human neocortex in patients with neocortical and mesial temporal lobe epilepsy: identification with in situ microvoltammetry Brain Res 899 2001 106 111
149. M.H. Baf, M.N. Subhash, K.M. Lakshmana, and B.S. Rao Sodium valproate induced alterations in monoamine levels in different regions of the rat brain Neurochem Int 24 1994 67 72
150. M.H. Meshkibaf, M.N. Subhash, K.M. Lakshmana, and B.S. Rao Effect of chronic administration of phenytoin on regional monoamine levels in rat brain Neurochem Res 20 1995 773 778
151. S.A. Sands, V. Guerra, and D.A. Morilak Changes in tyrosine hydroxylase mRNA expression in the rat locus coeruleus following acute or chronic treatment with valproic acid Neuropsychopharmacology 22 2000 27 35
152. H.R. Olpe, and R.S. Jones The action of anticonvulsant drugs on the firing of locus coeruleus neurons: selective, activating effect of carbamazepine Eur J Pharmacol 91 1983 107 110
153. M.H. Baf, M.N. Subhash, K.M. Lakshmana, and B.S. Rao Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine Neurochem Res 19 1994 1139 1143
154. S.B. Waller, and G.G. Buterbaugh Convulsive thresholds and severity and the anticonvulsant effect of phenobarbital and phenytoin in adult rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine during postnatal development Pharmacol Biochem Behav 23 1985 473 478
155. M.F. Mendez, J.L. Cummings, and D.F. Benson Depression in epilepsy. Significance and phenomenology Arch Neurol 43 1986 766 770
156. P. Wiegartz, M. Seidenberg, A. Woodard, B. Gidal, and B. Hermann Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression Neurology 53 5 Suppl 2 1999 S3 S8
157. V. Chan-Palay, and E. Asan Quantification of catecholamine neurons in the locus coeruleus in the human brain of normal young and older adults and in depression J Comp Neurol 287 1989 357 372
158. P.C. Jobe, J.W. Dailey, and J.F. Wernicke A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders Crit Rev Neurobiol 13 1999 317 356
159. A.M. Kanner, and A. Balabanov Depression and epilepsy: how closely related are they? Neurology 58 8 Suppl 5 2002 S27 S39
160. J.D. Leander Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116) Epilepsia 33 1992 573 576
161. E.J. Hernandez, P.A. Williams, and F.E. Dudek Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy Epilepsia 43 2002 1337 1345
162. E. Favale, V. Rubino, P. Mainardi, G. Lunardi, and C. Albano Anticonvulsant effect of fluoxetine in humans Neurology 45 1995 1926 1927
163. M. Hajos, J.C. Fleishaker, J.K. Filipiak-Reisner, M.T. Brown, and E.H. Wong The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile CNS Drug Rev 10 2004 23 44
164. K.U. Kuhn, B.B. Quednow, M. Thiel, P. Falkai, W. Maier, and C.E. Elger Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants Epilepsy Behav 4 2003 674 679
165. J.W. Dailey, and D.K. Naritoku Antidepressants and seizures: clinical anecdotes overshadow neuroscience Biochem Pharmacol 52 1996 1323 1329
166. B.M. Power, L.P. Hackett, L.J. Dusci, and K.F. Ilett Antidepressant toxicity and the need for identification and concentration monitoring in overdose Clin Pharmacokinet 29 1995 154 171
167. K. Matthews, and M.S. Eljamel Vagus nerve stimulation and refractory depression: please can you switch me on doctor? Br J Psychiatry 183 2003 181 183
168. P. Rutecki Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation Epilepsia 31 Suppl 2 1990 S1 S6
169. J.W. Woodbury, and D.M. Woodbury Vagal stimulation reduces the severity of maximal electroshock seizures in intact rats: use of a cuff electrode for stimulating and recording Pacing Clin Electrophysiol 14 1991 94 107
170. C.M. DeGiorgio, A. Amar, and M.L.J. Apuzzo Surgical anatomy, implantation technique, and operative complications S.C. Schachter D. Schmidt Vagus nerve stimulation 2001 Martin Dunitz London 31 50
171. M. Frost, J. Gates, S.L. Helmers, J.W. Wheless, P. Levisohn, C. Tardo, and J.A. Conry Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome Epilepsia 42 9 2001 1148 1152
172. C.M. DeGiorgio, J. Thompson, P. Lewis, S. Arrambide, D. Naritoku, A. Handforth, D. Labar, P. Mullin, C. Heck, and VNS US Study Group Vagus nerve stimulation: analysis of device parameters in 154 patients during the long-term study Epilepsia 42 2001 1017 1020
173. D.K. Naritoku, W.J. Terry, and R.H. Helfert Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve Epilepsy Res 22 1995 53 62
174. B.R. Walker, A. Easton, and K. Gale Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius Epilepsia 40 8 1999 1051 1057
175. K.B. Clark, D.K. Naritoku, D.C. Smith, R.A. Browning, and R.A. Jensen Enhanced recognition memory following vagus nerve stimulation in human subjects Nat Neurosci 2 1999 94 98